ARCHIVES

Harkin, Specter Propose A $5.2-Billion Supplement For NIH. Senate Report Says NIH Funding At “Crisis Point.”

This article is from The Cancer Letter archive.

Vol. 34 No. 28 | July 18, 2008

Download PDF Visit The Full Archive

Related Articles

Avastin doubles progression-free survival in metastatic disease.

May 27, 2005

In Brief: ACOS Moves Up Schedule for TNM Staging System From 1986 To “As Expeditiously As Possible”

January 13, 1984

Boston Study Finds Adenocarcinoma Of Esophagus Increasing

July 14, 1989

In Brief: Pardee, Durant Head AASR, ASCO; Sartorell, Hellman Presidents Elect; ONS Reelects Johnson

May 31, 1985

In Brief: NCI Contract Plans Shaping Up As RFP “Season” Approaches; L-B Profit Told

September 13, 1974

Kadcyla Extends Median PFS In Open-Label Phase III Trial

October 25, 2013